Cargando…
Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice
Macrophage inflammation marks all stages of atherogenesis, and AMPK is a regulator of macrophage inflammation. We therefore generated myeloid α1AMPK knockout (MAKO) mice on the LDL receptor knockout (LDLRKO) background to investigate whether myeloid deletion of α1AMPK exacerbates atherosclerosis. Wh...
Autores principales: | Cao, Qiang, Cui, Xin, Wu, Rui, Zha, Lin, Wang, Xianfeng, Parks, John S., Yu, Liqing, Shi, Hang, Xue, Bingzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878417/ https://www.ncbi.nlm.nih.gov/pubmed/26822081 http://dx.doi.org/10.2337/db15-0917 |
Ejemplares similares
-
Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
por: Johnson, Lance A., et al.
Publicado: (2011) -
Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice
por: LeBlond, Nicholas D., et al.
Publicado: (2020) -
Omega-3 Polyunsaturated Fatty Acids Antagonize Macrophage Inflammation via Activation of AMPK/SIRT1 Pathway
por: Xue, Bingzhong, et al.
Publicado: (2012) -
The Full Capacity of AICAR to Reduce Obesity-Induced Inflammation and Insulin Resistance Requires Myeloid SIRT1
por: Yang, Zhenggang, et al.
Publicado: (2012) -
Oxidized LDL, insulin sensitivity and beta-cell function in newborns
por: Fang, Fang, et al.
Publicado: (2021)